-
How Near-Death Stress Creates Prometastatic Tumor States
2026-08-24
Conod, Silvano, and Ruiz i Altaba show that tumor cells surviving impending death can become stable prometastatic cells called PAMEs. Their study links ER stress, PERK-CHOP signaling, GLI and NANOG-dependent reprogramming, and a cytokine-mediated interaction with neighboring PIM cells to the origin of metastatic behavior.
-
HEY2, Mitochondrial Respiration, and Heart Failure
2026-08-24
This study identifies HEY2 as an evolutionarily conserved transcriptional brake on cardiac mitochondrial oxidative respiration. Through complementary zebrafish, mouse, human cardiomyocyte, and genome-wide analyses, it connects HEY2/HDAC1 repression of PPARGC1A, ESRRA, and CPT1-associated programs with reactive oxygen species, cardiomyocyte loss, and heart failure.
-
FDA-Approved Drugs Against MERS-CoV: Study Analysis
2026-08-23
De Wilde and colleagues screened 348 FDA-approved compounds and identified chloroquine, chlorpromazine, loperamide, and lopinavir as low-micromolar inhibitors of MERS-CoV replication in cell culture. The study illustrates how drug repurposing can rapidly generate antiviral leads, while also showing why cell-based activity must be separated from clinical efficacy.
-
VX-702: Practical p38α MAPK Workflows
2026-08-22
VX-702 combines potent, selective p38α MAPK inhibition with workflow flexibility for cytokine, arthritis, platelet, and cardiac injury studies. This guide translates its ATP-competitive profile and emerging activation-loop biology into practical assay design, controls, and troubleshooting decisions.
-
Toremifene Citrate: From ER Biology to Translation
2026-08-21
A translational framework for using Toremifene Citrate to connect estrogen receptor biology, assay design, comparative evidence, and breast cancer research strategy.
-
SPI1/miR-616-5p Axis in NSCLC Metastasis
2026-08-20
The reference study identifies an SPI1/miR-616-5p regulatory axis that promotes non-small cell lung cancer invasion and migration and shows that sulforaphane can disrupt this pathway. Its main translational innovation is an hyaluronic acid- and folic acid-modified mesoporous silica nanoparticle system that improves sulforaphane stability, uptake, tumor targeting, and anti-metastatic activity in NSCLC models.
-
GSH and GSSG Assay Kit for Redox Analysis
2026-08-20
The GSH and GSSG Assay Kit supports reduced glutathione detection and separate GSSG measurement in biological samples. Its DTNB-based spectrophotometric workflow reports a 0.5 μM detection limit under the stated kit configuration and provides a practical endpoint for oxidative stress research and redox state analysis.
-
Safe DNA Gel Stain for Phage DNA Workflows
2026-08-19
Safe DNA Gel Stain supports sensitive DNA and RNA gel analysis while enabling blue-light visualization that can help limit UV exposure and protect clonable DNA. Its flexible in-gel or post-electrophoresis formats are useful for plasmid checks, phage-genome quality control, and nucleic acid recovery workflows.
-
HyperScript RT SuperMix for qPCR in Innate Immunity
2026-08-19
HyperScript RT SuperMix for qPCR supports reliable cDNA synthesis for qPCR studies of cGAS-STING and RIG-I/MDA5-MAVS signaling. This article presents an assay-design framework that separates RNA quality, pathway activation, and biological interpretation in cancer immunology.
-
Nebivolol hydrochloride: β1 Signaling Workflows
2026-08-18
Build cleaner cardiovascular pharmacology experiments with a selective β1-adrenoceptor antagonist, while using a drug-sensitized yeast assay as an orthogonal check for TOR-related effects. This guide connects receptor-focused workflows, practical DMSO handling, and troubleshooting with evidence from a recent mTOR inhibitor discovery study.
-
Prostaglandin E2 in Pancreatic Organoid Workflows
2026-08-18
Prostaglandin E2 adds a tunable receptor-level perturbation to pancreatic ductal organoid studies without replacing the reference study’s high-efficiency small-molecule cocktail. This guide connects PGE2 handling, dose-response design, organoid phenotyping, and troubleshooting for inflammation research, epithelial injury studies, and screening workflows.
-
Safe DNA Gel Stain: A Safer Imaging Strategy
2026-08-17
Safe DNA Gel Stain supports sensitive DNA and RNA gel staining while helping laboratories replace UV-dependent workflows with blue-light visualization. This article presents an assay-centered framework for choosing stains, imaging conditions, and controls without confusing gel-based quality control with diagnostic detection.
-
Propranolol Rewires Burn Injury Metabolism
2026-08-17
This phase II randomized controlled trial links propranolol treatment after severe burn injury to coordinated changes in adipose-tissue metabolomics, lipidomics, hormone-sensitive lipase activity, and endoplasmic reticulum stress. The findings provide a mechanistic framework for understanding how β-adrenergic blockade may reduce postburn hypermetabolism and shift inflammatory lipid signaling.
-
β-Elemene Inhibits Adipogenesis via AMPK in 3T3-L1 Cells
2026-08-16
The reference study identifies β-Elemene as an inhibitor of MDI-induced adipogenesis in 3T3-L1 preadipocytes and links this effect to restoration of AMPK pathway activity. Its value is primarily mechanistic: the work connects lipid accumulation, insulin resistance-related glucose handling, and AMPK signaling in a defined cellular model while also clarifying the limits of extrapolating these findings to obesity treatment.
-
CCCP: Mitochondrial Proton Gradient Disruption
2026-08-15
CCCP, or carbonyl cyanide m-chlorophenyl hydrazine, is a research uncoupler that dissipates the mitochondrial proton motive force and inhibits oxidative phosphorylation. It is useful for controlled in vitro mitochondrial perturbation, but it is not an Alzheimer’s disease biomarker, treatment, or clinical reagent.